Regulated Amino H2O
$10.00
Important research use notice For qualified laboratory research only. Not for human or animal use.
Read notice ↗
Study areas
Product artwork. Refer to the supplied label and batch documentation.
PT-141
$55.00
Test results & batch recordsView available COAs, results & lot history
PT-141 is a catalog-listed research peptide associated with the bremelanotide literature and melanocortin-receptor pharmacology.
Bulk orders10–49 or 50+ units
Per product and strength, off the regular price. Automatic savings; discounts cannot be combined.
Complimentary 2-day delivery on bulk orders.
Order multiple products in bulk ↗Delivery & checkoutFree standard shipping on $100+
Complete your lab setupRegulated Amino H2O & insulated packaging
COMPLETE YOUR LAB SETUP
↗
CoolTemp Insulated Bag
$12.00
CONTINUE YOUR RESEARCH
Materials for your next study.
Explore related research materials and lab essentials. Choose a size and add it straight to your bag.
Shop all products ↗↗Lab essentials
CoolTemp Insulated Bag
NeurobiologyReceptor signaling↗Nasal formats
PT-141 + Oxytocin Nasal
NeurobiologyReceptor signaling↗Nasal formats
Selank + Oxytocin Nasal
Metabolic researchReceptor signaling↗Research peptides
GLP-2 TZ
Metabolic researchReceptor signaling↗Research peptides
GLP-3 R
Receptor signaling↗Research peptides
Oxytocin
DOCUMENTATION, MADE ACCESSIBLE
Verified test results
Review the evidence for PT-141 — 10 MG. Published results must be traceable to the original report and the lot on your packaging.
LATEST PUBLISHED RECORD
Batch PT10001
Freedom Diagnostics · Reported August 21, 2026
Identity
PT-141Method: LC-MS
Purity
99.95%Method: HPLC-UV
Net content
10.13 mgAppearance
White Lyophilized PowderHeavy metals
Not reportedSterility
Not reportedEndotoxin
Not reportedAdditional analysis
Not reportedReport method: HPLC with UV detection coupled with mass spectrometry (LC-MS).
Results are transcribed from the linked certificate after store review. Check the original report and match the lot before relying on a result. “Not reported” does not mean an analysis passed.
A TRACEABLE RESEARCH RECORD
Every batch on record.
The archive for PT-141 — 10 MG. Only published, reviewed records are listed; an absent lot has no published documentation here.
PT10001Reported August 21, 2026Latest record +
- Product
- PT-141 — 10 MG
- Laboratory
- Freedom Diagnostics
- Accession
- 2608141159
- Certificate product
- PT-141 10mg
- Identity
- PT-141Method: LC-MS
- Purity
- 99.95%Method: HPLC-UV
- Net content
- 10.13 mg
- Appearance
- White Lyophilized Powder
TECHNICAL SPECS
Compound & formulation information.
Catalog details and published reference information for PT-141. Reference compound properties are separate from the identity, composition, and results of an individual batch.
Catalog specification
- Product
- PT-141
- Format
- Vial-format material
- Listed package amount
- 10 MG
- Product code
- RA-13-10-MG
- Documentation
- Reviewed report available above
- Intended use
- Controlled laboratory research
Formulation & handling
Follow the supplied label and supplier documentation for handling and storage. A batch-specific storage temperature, shelf life, salt form, and complete formulation have not been verified here.
Ask for a specification sheet ↗Peptide · melanocortin receptor agonist
PT-141 (bremelanotide)
PT-141, also known as bremelanotide, is a synthetic peptide analog of alpha-melanocyte-stimulating hormone investigated through melanocortin receptor pharmacology. Published studies include animal experiments and controlled human trials using specified investigational preparations. Those findings characterize the studied substance and trial materials; they do not verify a supplier's peptide or nasal product.
PEER-REVIEWED LITERATURE
The research, with its sources.
Published compound and ingredient research is provided as scientific context for PT-141. These papers do not verify this supplier’s product, its finished formulation, or any batch. Study findings are specific to the model and conditions described.
- 01
PT-141: a melanocortin agonist for the treatment of sexual dysfunction
This report describes melanocortin pharmacology, neuronal activation measurements in animals, and physiological observations in human participants.
- 02
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Two randomized placebo-controlled trials evaluated protocol-defined bremelanotide preparations using patient-reported endpoints and adverse-event monitoring.
IMPORTANT RESEARCH USAGE NOTICE
For research. With responsibility.
PT-141 is offered exclusively for controlled laboratory research by qualified professionals. Not for human or animal use, consumption, or administration.
Products are not intended to diagnose, treat, cure, or prevent disease. Literature is provided for research reference and is not medical advice or evidence validating this product. Purchasers must meet the store’s research eligibility requirements and review the supplied documentation before use.
Read the research use policy ↗DOCUMENTATION, MADE ACCESSIBLE
Verified test results
Review the evidence for PT-141 — select mass. Published results must be traceable to the original report and the lot on your packaging.
No verified batch results are published yet.
PT-141 — select mass documentation will appear here after the actual report is uploaded and reviewed. No purity, identity, or pass/fail result is implied.
Request a batch COA →Identity
Not reportedAwaiting the original batch certificate.
Purity
Not reportedAwaiting the original batch certificate.
Net content
Not reportedAwaiting the original batch certificate.
Microbiological results
Not reportedAwaiting the original batch certificate.
A TRACEABLE RESEARCH RECORD
Every batch on record.
The archive for PT-141 — select mass. Only published, reviewed records are listed; an absent lot has no published documentation here.
No batch records have been published for this product yet.
Ask about your batch ↗